Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Shareholders' Equity (Unaudited)

v3.20.2
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2018 11,956,874        
Balance at Dec. 31, 2018   $ 62,993 $ (45,968) $ 17,025
Share-based compensation expense   130 130
Unrealized gain (loss) on marketable securities   3 3
Net loss   (3,252) (3,252)
Balance (in shares) at Mar. 31, 2019 11,956,874        
Balance at Mar. 31, 2019   63,123 3 (49,220) 13,906
Balance (in shares) at Dec. 31, 2018 11,956,874        
Balance at Dec. 31, 2018   62,993 (45,968) 17,025
Unrealized gain (loss) on marketable securities         6
Net loss         (8,169)
Balance (in shares) at Sep. 30, 2019 12,006,874        
Balance at Sep. 30, 2019   63,831 6 (54,137) 9,700
Balance (in shares) at Mar. 31, 2019 11,956,874        
Balance at Mar. 31, 2019   63,123 3 (49,220) 13,906
Exercise of common stock options (in shares) 50,000        
Exercise of common stock options   75 75
Share-based compensation expense   182 182
Unrealized gain (loss) on marketable securities   8 8
Net loss   (2,469) (2,469)
Balance (in shares) at Jun. 30, 2019 12,006,874        
Balance at Jun. 30, 2019   63,380 11 (51,689) 11,702
Share-based compensation expense   451 451
Unrealized gain (loss) on marketable securities   (5) (5)
Net loss   (2,448) (2,448)
Balance (in shares) at Sep. 30, 2019 12,006,874        
Balance at Sep. 30, 2019   63,831 6 (54,137) 9,700
Balance (in shares) at Dec. 31, 2019 12,006,874        
Balance at Dec. 31, 2019   64,232 2 (56,617) 7,617
Issuance of common shares net of offering costs (in shares) 2,125,000        
Issuance of common shares net of offering costs   7,682 7,682
Exercise of common stock options (in shares) 7,200        
Exercise of common stock options   16 16
Share-based compensation expense   393 393
Unrealized gain (loss) on marketable securities   40 40
Net loss   (2,425) (2,425)
Balance (in shares) at Mar. 31, 2020 14,139,074        
Balance at Mar. 31, 2020   72,323 42 (59,042) 13,323
Balance (in shares) at Dec. 31, 2019 12,006,874        
Balance at Dec. 31, 2019   64,232 2 (56,617) 7,617
Unrealized gain (loss) on marketable securities         8
Net loss         (8,092)
Balance (in shares) at Sep. 30, 2020 18,739,074        
Balance at Sep. 30, 2020   94,457 10 (64,709) 29,758
Balance (in shares) at Mar. 31, 2020 14,139,074        
Balance at Mar. 31, 2020   72,323 42 (59,042) 13,323
Share-based compensation expense   436 436
Unrealized gain (loss) on marketable securities   (13) (13)
Net loss   (2,474) (2,474)
Balance (in shares) at Jun. 30, 2020 14,139,074        
Balance at Jun. 30, 2020   72,759 29 (61,516) 11,272
Issuance of common shares net of offering costs (in shares) 4,600,000        
Issuance of common shares net of offering costs   21,190 21,190
Share-based compensation expense   508 508
Unrealized gain (loss) on marketable securities   (19) (19)
Net loss   (3,193) (3,193)
Balance (in shares) at Sep. 30, 2020 18,739,074        
Balance at Sep. 30, 2020   $ 94,457 $ 10 $ (64,709) $ 29,758